![](https://clsbluesky.law.columbia.edu/wp-content/uploads/sites/2/2023/02/kang-1-e1676416747931.jpeg?w=150)
![](https://clsbluesky.law.columbia.edu/wp-content/uploads/sites/2/2023/02/kim-e1676416625200.png?w=150)
![](https://clsbluesky.law.columbia.edu/wp-content/uploads/sites/2/2023/02/si-e1676416815122.jpg?w=150)
Profiting from Rival Firms’ Cyberattacks
In a recent case, the Securities and Exchange Commission (SEC) pursued an unconventional form of insider trading involving Medivation Inc., an oncology-focused biopharmaceutical firm and one of its former, senior executives. According to the SEC, the executive profited from trading …